Trial · NCT00867100
Adverse events1,222
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 1,222
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Conjunctival Irritation | Eye disorders | Placebo Part B | 1 | 5 | |
| other | Conjunctival Irritation | Eye disorders | Cohort 10: 140 mg Sc Part B | 0 | 4 | |
| other | Conjunctival Irritation | Eye disorders | Cohort 11: 350 mg Sc Part B | 0 | 8 | |
| other | Conjunctival Irritation | Eye disorders | Cohort 9: 700 mg IV Part B | 1 | 8 | |
| other | Conjunctival Irritation | Eye disorders | Placebo Part A | 0 | 14 | |
| other | Conjunctival Irritation | Eye disorders | Cohort 1: 7mg SC Part A | 0 | 6 | |
| other | Conjunctival Irritation | Eye disorders | Cohort 2: 21mg SC Part A | 0 | 6 | |
| other | Conjunctival Irritation | Eye disorders | Cohort 3: 21mg IV Part A | 0 | 3 | |
| other | Conjunctival Irritation | Eye disorders | Cohort 4: 70mg SC Part A | 0 | 6 | |
| other | Conjunctival Irritation | Eye disorders | Cohort 5: 210mg SC Part A | 0 | 6 | |
| other | Conjunctival Irritation | Eye disorders | Cohort 6: 210mg IV Part A | 0 | 4 | |
| other | Conjunctival Irritation | Eye disorders | Cohort 7: 420mg SC Part A | 0 | 6 | |
| other | Conjunctival Irritation | Eye disorders | Cohort 8: 700mg IV Part A | 0 | 6 | |
| other | Conjunctivitis | Eye disorders | Placebo Part B | 1 | 5 | |
| other | Conjunctivitis | Eye disorders | Cohort 10: 140 mg Sc Part B | 0 | 4 | |
| other | Conjunctivitis | Eye disorders | Cohort 11: 350 mg Sc Part B | 0 | 8 | |
| other | Conjunctivitis | Eye disorders | Cohort 9: 700 mg IV Part B | 0 | 8 | |
| other | Conjunctivitis | Eye disorders | Placebo Part A | 0 | 14 | |
| other | Conjunctivitis | Eye disorders | Cohort 1: 7mg SC Part A | 0 | 6 | |
| other | Conjunctivitis | Eye disorders | Cohort 2: 21mg SC Part A | 0 | 6 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00867100/events